HUPO 2022 World Congress

#HUPO 2022 Starts December 4, 2022

HUPO 2022 Speakers

Get to Know the Speakers

Meet the speakers for the HUPO 2022. In order to learn more about each individual speaker, please click on the photos below.

Main Congress Speakers

Prof. Tony Purcell

Categories: Keynote Speakers, Main Congress Speakers
Prof. Tony Purcell: Australia
Tony is a NHMRC Principal Research Fellow and Deputy Head Department of Biochemistry at Monash University. He is also Vice President of the Australasian Proteomics Society, a HuPO council member and serves as a Scientific Advisory Board Member of the Human Proteome Project.
He is an Executive Advisory Board member of the journal Proteomics, an Associate Editor of Molecular Immunology and an Editorial Board Member of Molecular and Cellular Proteomics. He consults widely for industry and is on the Scientific Advisory Board of Evaxion Biotech and Bioinformatics Solutions.
His laboratory focusses on how the peptide antigens presented to the immune system, coined the immunopeptidome, is influenced by infection, inflammation and the environment. He has made important contributions to understanding the role of antigen in autoimmune diseases, drug hypersensitivity, cancer and infectious diseases. He is well known for work that has highlighted a role for post-translationally modified antigens in immunity. He has been instrumental in bringing new quantitative tools to immunological studies, in particular the quantitation of the cell surface expression levels of specific HLA-peptide complexes. He is a leader in the field of immunopeptidomics with over 270 related publications.

Prof. Tony Purcell

Click To Read Bio

Prof. Robert Moritz

Categories: Keynote Speakers, Main Congress Speakers
Prof. Robert Moritz: USA
Head,
Proteomics Research

Prof. Robert Moritz

Click To Read Bio

Prof. Jay Thelen

Categories: Keynote Speakers, Main Congress Speakers
Prof. Jay Thelen: USA
I earned my B.S. degree from the University of Nebraska-Lincoln in 1993 and my Ph.D. at the University of Missouri (MU) studying the regulation of the maize mitochondrial pyruvate dehydrogenase protein complex. In 1999 I began a postdoctoral position at Michigan State University investigating the regulation of plastid acetyl-CoA carboxylase (ACCase), a protein complex that catalyzes the committed step for de novo fatty acid synthesis. In 2002, I returned to MU to be the Associate Director of the Proteomics Center. Then in 2004 I joined the MU Biochemistry Department as an Assistant Professor and was promoted to Associate Professor in 2009 then Full Professor in 2016. My lab studies fatty acid biosynthesis in plants, specifically elucidating the unique regulatory properties of plant ACCase and leveraging these new discoveries to engineer higher oil in crops. Additionally, my research interests include plant metabolic regulation, seed development, protein phosphorylation, and quantitative proteomics approaches to study biological systems. I have authored over 140 publications, 5 patents, and founded a startup company. In 2011, I was awarded both the Presidential Early Career Award for Research Excellence and the Chancellor’s Award for Outstanding Research and Creative Activity from MU.

Prof. Jay Thelen

Click To Read Bio

Prof. Edward M. Marcotte

Categories: Keynote Speakers, Main Congress Speakers
Prof. Edward M. Marcotte: USA
Edward Marcotte is a Professor in the Department of Molecular Biosciences at the University of Texas at Austin, where he holds the Mr. and Mrs. Corbin J. Robertson, Sr. Regents Chair in Molecular Biology. He is an evolutionary biochemist whose research broadly uses tools of proteomics, bioinformatics, and systems and synthetic biology, with current work focused on the interactions, dynamics, and evolution of proteins across the tree of life. Marcotte has authored 230 journal publications and 22 issued/in process patents, received a National Institutes of Health Director’s Pioneer Award, is an elected Fellow of the Royal Society of Chemistry, the American Academy of Microbiology, and the American Association for the Advancement of Science, and co-founded the single-molecule protein sequencing company Erisyon, Inc.

Prof. Edward M. Marcotte

Click To Read Bio

Prof. Claudia Langenberg

Categories: Keynote Speakers, Main Congress Speakers
Prof. Claudia Langenberg: UK
Claudia Langenberg is Professor of Computational Medicine at the Berlin Institute of Health at Charité (BIH) and MRC Investigator and Programme Leader at the MRC Epidemiology Unit at the University of Cambridge. Her research is focused on the genetic basis of metabolic control, and her team studies its effects on health through integration of molecular with clinical data in large-scale patient and population-based studies.

Prof. Claudia Langenberg

Click To Read Bio

Prof. Claire Eyers

Categories: Keynote Speakers, Main Congress Speakers
Prof. Claire Eyers: UK
CLAIRE E. EYERS, BSC, PHD, FRSC – BIOSKETCH
Claire Eyers is a Professor of Biological Mass Spectrometry in the Institute of Systems, Molecular & Integrative Biology at the University of Liverpool (UoL), Director of the Centre for Proteome Research (CPR), and Associate Pro Vice Chancellor (Research & Impact) for the Faculty of Health and Life Sciences.
Having obtained a PhD (2002) in Biochemistry from the University of Dundee (Prof. Sir P. Cohen), she undertook postdoctoral studies at the University of Colorado, Boulder (Prof. N. Ahn) and then in the Michael Barber Centre for Mass Spectrometry, University of Manchester (Prof. S. Gaskell), where she became Acting Director (2009–2013). Her research exploits biophysical and biochemical methodologies to understand the structure and relevance of post-translational modifications (PTMs) and their roles in regulating cellular signalling in health and disease. She has established expertise in the development of mass spectrometric (MS)-based methods, and exploits separation technologies, including ion mobility spectrometry (IMS), for the structural investigation of proteins and the effects of PTMs and ligand binding.

Prof. Claire Eyers

Click To Read Bio

Prof. Chris Overall

Categories: Keynote Speakers, Main Congress Speakers
Prof. Chris Overall: Canada
Christopher Overall is a Tier 1 Canada Research Chair in Protease Proteomics and an Honorary Professor Albert-Ludwigs Universität Freiburg, Germany. He was inducted as a fellow into the Royal Society of Canada in 2018 and is Chair of the HUPO C-HPP. He is best known for his development of proteomic methodology for discovering protein N and C-termini and protease substrates in vivo, thereby establishing the field of terminomics, also known as degradomics. By generating clinically relevant insights into how proteases dampen disease-fighting defence systems involved in inflammation and immunodeficiency, degradomics has revealed a new layer of complexity in the hierarchy of cell and immune signalling regulation, revolutionizing our understanding of protease function and drug targeting. These insights led to the development of a new class of molecular correctors to treat MALT-1 protease deficiency and NF-kB activation in immunodeficiency disease. In the pandemic, Chris pivoted his laboratory to the investigation of SARS-CoV-2 proteases, revealing their drastic impact on cleaving hundreds of host cell proteins in critical pathways that promote the cellular takeover by the virus. His advances in proteomics have been recognized by the CNPN Tony Pawson Award (2014) and the 2018 HUPO Discovery Award. He is an Associate Editor of the Journal of Proteome Research.

Prof. Chris Overall

Click To Read Bio

Prof. Anne-Claude Gingras

Categories: Keynote Speakers, Main Congress Speakers
Prof. Anne-Claude Gingras: Canada

Anne-Claude Gingras is the Canada Research Chair in Functional Proteomics, the Lea Reichmann Chair in Cancer Proteomics and a Senior Investigator at the Lunenfeld-Tanenbaum Research Institute, Sinai Health System. A Full Professor in the department of Molecular Genetics at the University of Toronto, she also serves as as deputy editor of Molecular and Cellular Proteomics and as a co-director of the Network Biology Collaborative Centre (a Genome Canada technology platform). Her lab focuses on the study of signalling pathways using systematic approaches and the development of quantitative proteomics technologies. She has developed computational tools that enable better analysis and visualization of proteomics results, and contribute to training the next generation of proteomics researchers. Using the tools that she developed, her group has identified new protein complexes and signaling components that provide a better understanding of perturbations associated with cancer and rare diseases. She also contributed to Canada’s response to the COVID-19 pandemic by developing high-throughput serology assays. Dr. Gingras has published >275 research articles and review articles that have already been cited 47K times.

Prof. Anne-Claude Gingras

Click To Read Bio

Prof. Amanda Hummon

Categories: Keynote Speakers, Main Congress Speakers
Prof. Amanda Hummon: USA

Prof. Amanda Hummon

Click To Read Bio

Prof. Alexey Nesvizhskii

Categories: Keynote Speakers, Main Congress Speakers
Prof. Alexey Nesvizhskii: USA
Alexey Nesvizhskii is the Godfrey Dorr Stobbe Professor of Bioinformatics in the Departments of Pathology and Computational Medicine & Bioinformatics, University of Michigan Medical School, Ann Arbor. His research laboratory (www.nesvilab.org) is working in the area of mass spectrometry based proteomics and proteogenomics, bioinformatics, and multi-omics data integration. Dr. Nesvizhskii’s research contributions include the development of concepts and computational methods implemented in many widely used bioinformatics tools, including PeptideProphet and ProteinProtein, CRAPome, SAINT, DIA-Umpire, MSFragger, IonQuant, Philosopher, and FragPipe (https://fragpipe.nesvilab.org/). His lab actively collaborates with technology developers, biologists, and clinical scientists. He has served on the Board of Directors for the American Society of Mass Spectrometry (ASMS), US HUPO, and on the Scientific Advisory Board for Swiss Institute of Bioinformatics. At the University of Michigan, Dr. Nesvizhskii directs the NCI-funded T32 Proteogenomics of Cancer Training Program and the University of Michigan Proteogenomics Data Analysis Center (UM-PGDAC; part of the Clinical Proteomic Tumor Analysis Consortium initiative). He also Directs the Proteomics Resource Facility which provides cutting-edge proteomics capabilities to UM investigators.

Prof. Alexey Nesvizhskii

Click To Read Bio

Marc Wilkins

Categories: Keynote Speakers, Main Congress Speakers
Marc Wilkins: Australia

In 1994 Marc Wilkins developed the concept of the proteome and coined the term. In 1997 he co-wrote and co-edited the first book on proteomics. Since that time, Marc has published >250 peer-reviewed research papers, review papers and book chapters and has edited 2 books in the field of proteomics, genomics and systems biology. In proteomics, a recent focus has been to construct a complete methylproteome network in a model organism, and to study its regulatory properties. In genomics, recent highlights have included the sequencing and assembly of the koala genome and collaborative work in the RNA atlas project.

In industry, Marc has co-founded two biotechnology companies. Proteome Systems Limited (1999), in which he worked for 6 years, was a proteomics diagnostics and technology development company. Regeneus (2007) is a regenerative medicine company that recently licensed its core product to a Japanese multinational. At UNSW, Marc is a Professor of Systems Biology. He has been Director of the Ramaciotti Centre for Genomics since 2011 and has grown that to be the largest such facility at any Australian university.

Marc is an elected member of the Council of HUPO, and was a co-organiser of HUPO2010 in Sydney and then HUPO2019 in Adelaide. Marc also serves as an elected member of the Australian Proteomics Society’s Committee of Management.

Marc Wilkins

Click To Read Bio

György Marko Varga

Categories: Keynote Speakers, Main Congress Speakers
György Marko Varga: Sweden

The major research foci of György Marko-Varga are clinical studies, drug characterisation within Cancerous disease and Biobanking.

GYORGY is the Head of the European Cancer Moonshot Lund Center, with a focus on Melanoma and Lung Cancer.

Malignant Melanoma is the most frequently mutated tumor type with approx 50% of the cases harbor activating BRAF mutations, that is the key driver. Large scale studies are undertaken in multi-center studies, currently establishing the largest Molecular Pathology database with 700 patients and resulting 65 million sequence files, where most WHO Melanoma classes have been mapped and characterized.

We have developed digital pathology image libraries, establishing a morphology index pathology basis with a single cell annotation resolution, targeting clone specificificity of Melanoma cancer cell types, as well as stromal phenotypes that interplay and generates an initiation of the Metastasis spread.

ProteoGenomics expression on whole tumor sections, tumor compartments, and clone specific expressions are generated – adressing metastasis activation and developments, as well as mode-of-drug-action mechanisms, and the challenges realting to resistence and Cancer relapses.

Our major objective within the European Cancer Moonshot Center is to build medical knowledge on an individual patient basis by applying ProteoGenomics positioned in the heart of Cancer clinics, collaborating with oncologists, surgery and pathologists.

György Marko Varga

Click To Read Bio

Dr. Neil Kelleher

Categories: Keynote Speakers, Main Congress Speakers
Dr. Neil Kelleher: USA
Neil L. Kelleher, PhD is the director of the 50-person Proteomics Center of Excellence and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. His research is focused in the areas of top-down proteomics, natural products discovery, and cancer biology. Dr. Kelleher and his team drives both technology development and applications of very high performance mass spectrometry in proteomics and metabolomics. For bacteria and fungi, new platforms now feed compounds from the natural world into pharmaceutical pipelines.  In proteomics, Kelleher has emerged as a leading voice in a calling for an analogue of the Human Genome Project applied to human proteins.  This effort is called the Human Proteoform Project and has recently been endorsed by research consortia.  Neil is a serial entrepreneur with experience in spinning up four small companies, including a software shop providing the leading search engine used in >1000 labs for “top down proteomics”. His contributions to the fields of proteomics and natural products chemistry have been recognized by multiple awards, including the Biemann Medal from the American Society for Mass Spectrometry, the Pfizer Award in Enzyme Chemistry from the American Chemical Society, a Searle Scholar Award, a Packard Fellowship, and the Allen Distinguished Investigator Award.
Basic metrics for the Kelleher academic operation are:  H-factor ~75; >380 total publications; 50 Ph.D. students; >150 postdoctoral trainees.

Dr. Neil Kelleher

Click To Read Bio

Dr. Mikhail Savitski

Categories: Keynote Speakers, Main Congress Speakers
Dr. Mikhail Savitski: Germany
PhD in mass spectrometry at Uppsala university 2007. Group leader at Cellzome GSK from 2008-2015. Team leader and head of proteomics core facility at EMBL since 2016. The research group at EMBL develops novel proteomic technologies and applies them to study post-translational regulation.

Dr. Mikhail Savitski

Click To Read Bio

Dr. Kiyoko Aoki-Kinoshita

Categories: Keynote Speakers, Main Congress Speakers
Dr. Kiyoko Aoki-Kinoshita: Japan

Glycoinformatics researcher since 2003, responsible for the glycan repository GlyTouCan, the glycomics MS repositories GlycoPOST (raw data) and UniCarb-DR (glycans), which are all accessible from the glycoscience Web portal GlyCosmos.

Dr. Kiyoko Aoki-Kinoshita

Click To Read Bio

Dr. Jennifer van Eyk

Categories: Keynote Speakers, Main Congress Speakers
Dr. Jennifer van Eyk: USA
Dr. Jennifer Van Eyk is currently the director of the Advanced Biosystems Research Institute at Cedars-Sinai Medical Center, LA and she also holds the inaugural Erika Glazer Endowed Chair in Women’s Heart Health. Dr. Van Eyk’s lab focuses on developing technical pipelines for de novo discovery and larger scale quantitative mass spectrometry methods for the continuous assessments of cohorts focusing on health assessment. The Precision Biomarkers Laboratories, an outgrowth of her lab, is comprised of three independent commercial laboratories, aimed at facilitating the move from discovery to clinical assays for personalized biomarkers. Current, she is part of the Innovation Center, driving single cell phenotyping of patients samples for individualized therapy development.

Dr. Jennifer van Eyk

Click To Read Bio

Dr. Jean Armengaud

Categories: Keynote Speakers, Main Congress Speakers
Dr. Jean Armengaud: France

Jean Armengaud is specialized in mass spectrometry for biology and more specifically in proteogenomics and metaproteomics. He manages the ProGénoMIX platform located near Avignon in France. He wishes to contribute to a better understanding of the functioning of complex biological systems and exploit this knowledge for medical and environmental purposes. He received his PhD in Biochemistry in 1994 at the University of Grenoble.

Dr. Jean Armengaud

Click To Read Bio

Dr. Ashok Dongre

Categories: Keynote Speakers, Main Congress Speakers
Dr. Ashok Dongre: USA
Ashok Dongre is currently Scientific Director & Head of Proteomics in the Research & Early Development organization at Bristol Myers Squibb. He also manages the Genetically Modified Animal Alliances group.
Earned his B.Sc. & M.Sc. in Chemistry from University of Mumbai and Ph.D. in Analytical Chemistry (Vicki Wysocki) at Virginia Commonwealth University. Ph.D research led to the formulation of the “Mobile Proton Model” which elucidates peptide ion fragmentation mechanisms. Trained as HHMI post-doc at University of Washington with Alexander Rudensky & John Yates III.
Over 24-year tenure at BMS, his team is focused on innovating in proteomics space to address challenges at the intersection of disease pathophysiology and bio-pharmaceutical research. He served on NIH and NIAA review panels. He is a peer reviewer for several scientific journals.
Current research includes applying innovative methods to rapidly maturing novel therapeutic modality of Targeted Protein Degradation. This modality garners the potential to unlock the undruggable proteome bringing novel therapies to patients with unmet medical need. Group continues to elucidate innovative biomarker hypothesis across pathologies ranging from cancer to auto immunity and heart failure.
Authored / co-authored over 46 peer-reviewed scientific publications and numerous (>60) presentations. Three issued US Patents each with foreign equivalents.

Dr. Ashok Dongre

Click To Read Bio

Asst. Prof. Justyna Fert-Bober

Categories: Keynote Speakers, Main Congress Speakers
Asst. Prof. Justyna Fert-Bober: USA

I am an Assistant Professor at Cedars-Sinai Heart Institute, with a broad background of biochemistry, molecular biology, immunology, and proteomics to study organ function and regulation in health and disease. My research involves inter-institutional collaborations focused on identifying novel and/or largely understudied biologic markers of heart failure (HF) with the major role of proteins posttranslational modifications (PTMs). I am pioneer in the understanding of arginine deiminases, enzymes family that introduce PTM, called citrullination and their contributions to many processes, like aging, inflammation, and their link with disease development and progression. Uncovering these biological bases are long term goals of my lab expanding to other physiological or pathological conditions. In fact, the COVID-19 pandemic experience has profoundly impact research at my lab and our work has been focuses on i) sex and race differences in both susceptibility and response to SARS-CoV-2 exposure and response to SARS-COV-2 infection; ii) sex and race differences in both positive and negative response to SARS-CoV-2 vaccine, and iii) linking adaptive immune response – autoimmunity with Long COVID, post-acute sequelae of SARS-CoV-2 infection. The concept of profiling autoantibodies in healthy and disease patients combined with multi-omic data will form the basis of disease prediction allowing for earlier intervention linked to disease prevention strategies, as well as earlier, effective and personalized interventions for established disease.

Asst. Prof. Justyna Fert-Bober

Click To Read Bio

Asst. Prof. Jennifer Geddes McAlister

Categories: Keynote Speakers, Main Congress Speakers
Asst. Prof. Jennifer Geddes McAlister: Canada

Dr. Jennifer Geddes-McAlister started her appointment as Assistant Professor in the Department of Molecular and Cellular Biology at the University of Guelph in July 2018. She is an expert in mass spectrometry-based proteomics following a Alexander von Humboldt post-doctoral fellowship at the Max Planck Institute of Biochemistry (Germany). Her research program aims to define the relationship between host and pathogen during infection to uncover new strategies for overcoming resistance in both medically- and agriculturally-relevant diseases. Dr. Geddes-McAlister is the elected Vice President, Communications and Board member for the Canadian National Proteomics Network (CNPN), co-Founder of the Canadian Proteomics and Artificial Intelligence Research and Training Consortium (CanProAI), and the elected Western Hemisphere Diversity Candidate for the Human Proteome Organization (HUPO). She recently founded ‘Moms in Proteomics’, an initiative dedicated to mentoring and supporting mothers in STEM and foudnded the CNPN Unity initiative to promote equity, diversity, and inclusion in proteomics research and training across Canada.

Asst. Prof. Jennifer Geddes McAlister

Click To Read Bio

Assoc. Prof. Ryan Kelly

Categories: Keynote Speakers, Main Congress Speakers
Assoc. Prof. Ryan Kelly: USA
Ryan Kelly received his Ph.D. in analytical chemistry from Brigham Young University (BYU) in 2005 and spent the next 13 years at Pacific Northwest National Laboratory. He joined the Chemistry faculty of BYU as an Associate Professor in 2018. A central theme of Dr. Kelly’s research has been the development of new technological solutions for ultrasensitive biochemical analyses. He has developed ultra-low-flow electrospray ionization sources, improved MS ion optics and custom separations based on nanoflow liquid chromatography and capillary electrophoresis. Dr. Kelly’s efforts have recently focused on single-cell, spatial and other low-input MS-based proteomic analyses. His team developed the nanoPOTS workflow, which enables in-depth profiling of protein expression from single cells and makes possible high-resolution proteome imaging of tissues. His research continues to focus on improvements in sensitivity, throughput and quantification for single-cell proteomics and other sample-limited analyses. Dr. Kelly has authored or coauthored more than 100 publications and is a named inventor on several patents that have been licensed and commercialized by companies including Bruker, Cellenion and MicrOmics Technologies. His work has been recognized with several awards including R&D 100 awards, the Georges Guiochon HPLC Faculty Fellowship and the HTC Innovation Award.

Assoc. Prof. Ryan Kelly

Click To Read Bio

Assoc. Prof. Renã Robinson

Categories: Keynote Speakers, Main Congress Speakers
Assoc. Prof. Renã Robinson: USA
Dr. Renã A. S. Robinson, Associate Professor of Chemistry at Vanderbilt University and inaugural Dorothy J. Wingfield Phillips Chancellor’s Faculty Fellow, received her B.S. in Chemistry with concentration in Business from the University of Louisville and Ph.D. in Analytical Chemistry from Indiana University under the mentorship of Professor David Clemmer. She developed proteomics methods to study aging in Drosophila (fruit flies) and continued working in aging as a Lyman T. Johnson Postdoctoral Fellow with Professor D. Allan Butterfield at the University of Kentucky. During this fellowship she began to focus on neurodegenerative disorders such as Alzheimer’s disease and received a UNCF/Merck Postdoctoral Fellowship.
Dr. Robinson joined the Department of Chemistry at the University of Pittsburgh as Assistant Professor in 2009 and moved to Vanderbilt University in 2017. She has a nationally and internationally recognized research program and is a leader in the field of proteomics for her work in aging, Alzheimer’s disease, and applications relevant to human health and disparities. Her laboratory is especially focused on using advancing proteomics and lipidomics technologies to further understanding of health disparities in Alzheimer’s disease. Dr. Robinson is a Co-Investigator of the Recruitment Innovations for Diversity Enhancements NIH Award to understand the effectiveness of storytelling as a recruitment tool into Alzheimer’s disease research. She is an active member of several organizations serving underrepresented students and professionals in STEM, and is the President of the National Organization for the Professional Advancement of Black Chemists and Chemical Engineers (NOBCChE) and the faculty advisor for the Nashville Student and Professional Chapter of NOBCChE.

Assoc. Prof. Renã Robinson

Click To Read Bio

Assoc. Prof. Morten Thaysen-andersen

Categories: Keynote Speakers, Main Congress Speakers
Assoc. Prof. Morten Thaysen-Andersen: Australia
A/Prof Morten Thaysen-Andersen heads the Analytical Glycoimmunology group at Macquarie University, Sydney, Australia. His research program aims to advance our understanding of the human innate immune system and immune-related diseases including microbial infections, inflammation and cancer. His team develops and applies powerful glycomics and glycoproteomics technologies using advanced mass spectrometry while also drawing on analytical tools in protein and carbohydrate chemistry and methods in immunology, structural biology and molecular biology to unravel glycobiological processes of the innate immune system.

Assoc. Prof. Morten Thaysen-andersen

Click To Read Bio

Assoc. Prof. Jens Michael Schroeder

Categories: Keynote Speakers, Main Congress Speakers
Assoc. Prof. Jens Michael Schroeder: Germany
Dr. Schröder graduated in chemistry, received his diploma in chemistry 1976, and finished 1980 his Doctoral thesis in Organic Chemistry. 1979 he joined the Dpt. of Dermatology at the Kiel University as research assistant to study the role of neutrophils and chemotaxins in psoriasis. In 1984 he discovered in psoriatic scale extracts a novel chemotactic peptide, later named Interleukin 8 or CXCL-8. In 1994 Dr. Schröder was appointed as professor for the biochemistry of inflammation and became head of a Clinical Research Unit until his retirement in 2015. After discovery of the first human inducible peptide antibiotic beta-defensin-2 in 1997, again isolated from psoriatic scales, and the discovery of several other antimicrobial peptides from human skin, he became founder and thereafter speaker of the collaborative research center (SFB) “Molecular Mechanisms of Epithelial Defense” and later a co-founder of the Excellence Initiative “Inflammation at Interfaces”. 2011 he organized as co-chair a Gordon Research Conference on “Antimicrobial Peptides”. He has been a member of the editorial board of various international journals, received several prestigious awards and is member of the German National Academy of Sciences, Leopoldina.
He discovered or co-discovered several important molecules or its function, among them the chemokines IL-8, Gro-alpha, RANTES, Eotaxin, the antimicrobial peptides hBD-2, hBD-3, RNase-7, Psoriasin, cationic intrinsically disordered antimicrobial peptides (CIDAMPs) like Hornerin and Filaggrin-2, and the protease-inhibitors elafin, SPINK-9, SPINK-6, as well as chemotic lipids like 5-oxo-eicosanoids and a fungal diacylated urea. He contributed to the understanding of the role of ß-defensins as factors linking innate and adaptive immunity as well as understanding the role of cathelicidin in the psoriasis pathogenesis. He received the prestigious high risk “Reinhart-Koselleck”-grant of the DFG to investigate “resistance-avoiding antimicrobial principles of healthy human skin”.
Most of his discovered molecules were purified from lesional psoriatic scale extracts and subsequently characterized.

Assoc. Prof. Jens Michael Schroeder

Click To Read Bio

Assoc. Prof. Christine Vogel

Categories: Keynote Speakers, Main Congress Speakers
Assoc. Prof. Christine Vogel: USA
Dr. Christine Vogel is a trained biochemist with a Master’s in Mathematical Biology and a PhD in Computational Structural Biology obtained from the University of Cambridge, with Drs. Cyrus Chothia and Sarah Teichmann. After post-doctoral work with Dr. Edward Marcotte (Univ. of Texas at Austin), she joined New York University as faculty in 2011. Her lab uses a combination of proteomics, transcriptomics, computational, and targeted approaches to investigate the regulation of protein expression under stress. Her work was recognized by the US Human Proteomics Organization with the 2017 Robert J. Cotter New Investigator Award. The work is funded by the NIH and Chan Zuckerberg Initiative.

Assoc. Prof. Christine Vogel

Click To Read Bio

Assoc. Prof. Andreas Mund

Categories: Keynote Speakers, Main Congress Speakers
Assoc. Prof. Andreas Mund: Denmark
Andreas Mund is an associate professor in the clinical proteomics group of Professor Matthias Mann at the Novo Nordisk Foundation Center for Protein Research, University of Copenhagen. He has a dual education profile with a degree in biotechnology engineering from the Anhalt University of Applied Sciences and a PhD in protein biochemistry from the University of Hamburg. His research focuses on the characterization of single cell identity and heterogeneity in tissue biobank samples by a combination of high parametric imaging, artificial intelligence, and ultrahigh sensitive proteomics. This ‘Deep Visual Proteomics (DVP)’ technology deciphers the spatial molecular dimension by quantifying thousands of proteins in an unbiased manner. DVP couples in an unbiased way the physiological features of cells as seen in the microscope with the actual protein signature to understand mechanisms of health and disease.

Assoc. Prof. Andreas Mund

Click To Read Bio

Anjali Seth

Categories: Keynote Speakers, Main Congress Speakers
Anjali Seth: France

Anjali Seth studied Physics and Chemistry in Paris. She obtained her PhD from Pierre and Marie Curie University for her research on magnetic nanoparticles for targeted drug delivery and imaging. She then moved to Oxford, UK, for a postdoctoral project on magnetic particles and ultrasound for cancer theranostics. In 2019, she joined Cellenion, a company specialized in the field of single-cell isolation, to develop and lead the single cell proteomics R&D department. Since then, she had the opportunity to participate in the advancement of the cutting-edge field of single cell proteomics analyses using mass spectrometry. In Cellenion, she focuses on developing tools to facilitate and automate sample preparation workflows prior to analysis. Cellenion is now collaborating with most of the key opinion leader in the field.

Anjali Seth

Click To Read Bio

Pre-Congress Speakers

Prof. Tony Purcell

Categories: Keynote Speakers, Main Congress Speakers
Prof. Tony Purcell: Australia
Tony is a NHMRC Principal Research Fellow and Deputy Head Department of Biochemistry at Monash University. He is also Vice President of the Australasian Proteomics Society, a HuPO council member and serves as a Scientific Advisory Board Member of the Human Proteome Project.
He is an Executive Advisory Board member of the journal Proteomics, an Associate Editor of Molecular Immunology and an Editorial Board Member of Molecular and Cellular Proteomics. He consults widely for industry and is on the Scientific Advisory Board of Evaxion Biotech and Bioinformatics Solutions.
His laboratory focusses on how the peptide antigens presented to the immune system, coined the immunopeptidome, is influenced by infection, inflammation and the environment. He has made important contributions to understanding the role of antigen in autoimmune diseases, drug hypersensitivity, cancer and infectious diseases. He is well known for work that has highlighted a role for post-translationally modified antigens in immunity. He has been instrumental in bringing new quantitative tools to immunological studies, in particular the quantitation of the cell surface expression levels of specific HLA-peptide complexes. He is a leader in the field of immunopeptidomics with over 270 related publications.

Prof. Tony Purcell

Click To Read Bio

Prof. Robert Moritz

Categories: Keynote Speakers, Main Congress Speakers
Prof. Robert Moritz: USA
Head,
Proteomics Research

Prof. Robert Moritz

Click To Read Bio

Prof. Jay Thelen

Categories: Keynote Speakers, Main Congress Speakers
Prof. Jay Thelen: USA
I earned my B.S. degree from the University of Nebraska-Lincoln in 1993 and my Ph.D. at the University of Missouri (MU) studying the regulation of the maize mitochondrial pyruvate dehydrogenase protein complex. In 1999 I began a postdoctoral position at Michigan State University investigating the regulation of plastid acetyl-CoA carboxylase (ACCase), a protein complex that catalyzes the committed step for de novo fatty acid synthesis. In 2002, I returned to MU to be the Associate Director of the Proteomics Center. Then in 2004 I joined the MU Biochemistry Department as an Assistant Professor and was promoted to Associate Professor in 2009 then Full Professor in 2016. My lab studies fatty acid biosynthesis in plants, specifically elucidating the unique regulatory properties of plant ACCase and leveraging these new discoveries to engineer higher oil in crops. Additionally, my research interests include plant metabolic regulation, seed development, protein phosphorylation, and quantitative proteomics approaches to study biological systems. I have authored over 140 publications, 5 patents, and founded a startup company. In 2011, I was awarded both the Presidential Early Career Award for Research Excellence and the Chancellor’s Award for Outstanding Research and Creative Activity from MU.

Prof. Jay Thelen

Click To Read Bio

Prof. Edward M. Marcotte

Categories: Keynote Speakers, Main Congress Speakers
Prof. Edward M. Marcotte: USA
Edward Marcotte is a Professor in the Department of Molecular Biosciences at the University of Texas at Austin, where he holds the Mr. and Mrs. Corbin J. Robertson, Sr. Regents Chair in Molecular Biology. He is an evolutionary biochemist whose research broadly uses tools of proteomics, bioinformatics, and systems and synthetic biology, with current work focused on the interactions, dynamics, and evolution of proteins across the tree of life. Marcotte has authored 230 journal publications and 22 issued/in process patents, received a National Institutes of Health Director’s Pioneer Award, is an elected Fellow of the Royal Society of Chemistry, the American Academy of Microbiology, and the American Association for the Advancement of Science, and co-founded the single-molecule protein sequencing company Erisyon, Inc.

Prof. Edward M. Marcotte

Click To Read Bio

Prof. Claudia Langenberg

Categories: Keynote Speakers, Main Congress Speakers
Prof. Claudia Langenberg: UK
Claudia Langenberg is Professor of Computational Medicine at the Berlin Institute of Health at Charité (BIH) and MRC Investigator and Programme Leader at the MRC Epidemiology Unit at the University of Cambridge. Her research is focused on the genetic basis of metabolic control, and her team studies its effects on health through integration of molecular with clinical data in large-scale patient and population-based studies.

Prof. Claudia Langenberg

Click To Read Bio

Prof. Claire Eyers

Categories: Keynote Speakers, Main Congress Speakers
Prof. Claire Eyers: UK
CLAIRE E. EYERS, BSC, PHD, FRSC – BIOSKETCH
Claire Eyers is a Professor of Biological Mass Spectrometry in the Institute of Systems, Molecular & Integrative Biology at the University of Liverpool (UoL), Director of the Centre for Proteome Research (CPR), and Associate Pro Vice Chancellor (Research & Impact) for the Faculty of Health and Life Sciences.
Having obtained a PhD (2002) in Biochemistry from the University of Dundee (Prof. Sir P. Cohen), she undertook postdoctoral studies at the University of Colorado, Boulder (Prof. N. Ahn) and then in the Michael Barber Centre for Mass Spectrometry, University of Manchester (Prof. S. Gaskell), where she became Acting Director (2009–2013). Her research exploits biophysical and biochemical methodologies to understand the structure and relevance of post-translational modifications (PTMs) and their roles in regulating cellular signalling in health and disease. She has established expertise in the development of mass spectrometric (MS)-based methods, and exploits separation technologies, including ion mobility spectrometry (IMS), for the structural investigation of proteins and the effects of PTMs and ligand binding.

Prof. Claire Eyers

Click To Read Bio

Prof. Chris Overall

Categories: Keynote Speakers, Main Congress Speakers
Prof. Chris Overall: Canada
Christopher Overall is a Tier 1 Canada Research Chair in Protease Proteomics and an Honorary Professor Albert-Ludwigs Universität Freiburg, Germany. He was inducted as a fellow into the Royal Society of Canada in 2018 and is Chair of the HUPO C-HPP. He is best known for his development of proteomic methodology for discovering protein N and C-termini and protease substrates in vivo, thereby establishing the field of terminomics, also known as degradomics. By generating clinically relevant insights into how proteases dampen disease-fighting defence systems involved in inflammation and immunodeficiency, degradomics has revealed a new layer of complexity in the hierarchy of cell and immune signalling regulation, revolutionizing our understanding of protease function and drug targeting. These insights led to the development of a new class of molecular correctors to treat MALT-1 protease deficiency and NF-kB activation in immunodeficiency disease. In the pandemic, Chris pivoted his laboratory to the investigation of SARS-CoV-2 proteases, revealing their drastic impact on cleaving hundreds of host cell proteins in critical pathways that promote the cellular takeover by the virus. His advances in proteomics have been recognized by the CNPN Tony Pawson Award (2014) and the 2018 HUPO Discovery Award. He is an Associate Editor of the Journal of Proteome Research.

Prof. Chris Overall

Click To Read Bio

Prof. Anne-Claude Gingras

Categories: Keynote Speakers, Main Congress Speakers
Prof. Anne-Claude Gingras: Canada

Anne-Claude Gingras is the Canada Research Chair in Functional Proteomics, the Lea Reichmann Chair in Cancer Proteomics and a Senior Investigator at the Lunenfeld-Tanenbaum Research Institute, Sinai Health System. A Full Professor in the department of Molecular Genetics at the University of Toronto, she also serves as as deputy editor of Molecular and Cellular Proteomics and as a co-director of the Network Biology Collaborative Centre (a Genome Canada technology platform). Her lab focuses on the study of signalling pathways using systematic approaches and the development of quantitative proteomics technologies. She has developed computational tools that enable better analysis and visualization of proteomics results, and contribute to training the next generation of proteomics researchers. Using the tools that she developed, her group has identified new protein complexes and signaling components that provide a better understanding of perturbations associated with cancer and rare diseases. She also contributed to Canada’s response to the COVID-19 pandemic by developing high-throughput serology assays. Dr. Gingras has published >275 research articles and review articles that have already been cited 47K times.

Prof. Anne-Claude Gingras

Click To Read Bio

Prof. Amanda Hummon

Categories: Keynote Speakers, Main Congress Speakers
Prof. Amanda Hummon: USA

Prof. Amanda Hummon

Click To Read Bio

Prof. Alexey Nesvizhskii

Categories: Keynote Speakers, Main Congress Speakers
Prof. Alexey Nesvizhskii: USA
Alexey Nesvizhskii is the Godfrey Dorr Stobbe Professor of Bioinformatics in the Departments of Pathology and Computational Medicine & Bioinformatics, University of Michigan Medical School, Ann Arbor. His research laboratory (www.nesvilab.org) is working in the area of mass spectrometry based proteomics and proteogenomics, bioinformatics, and multi-omics data integration. Dr. Nesvizhskii’s research contributions include the development of concepts and computational methods implemented in many widely used bioinformatics tools, including PeptideProphet and ProteinProtein, CRAPome, SAINT, DIA-Umpire, MSFragger, IonQuant, Philosopher, and FragPipe (https://fragpipe.nesvilab.org/). His lab actively collaborates with technology developers, biologists, and clinical scientists. He has served on the Board of Directors for the American Society of Mass Spectrometry (ASMS), US HUPO, and on the Scientific Advisory Board for Swiss Institute of Bioinformatics. At the University of Michigan, Dr. Nesvizhskii directs the NCI-funded T32 Proteogenomics of Cancer Training Program and the University of Michigan Proteogenomics Data Analysis Center (UM-PGDAC; part of the Clinical Proteomic Tumor Analysis Consortium initiative). He also Directs the Proteomics Resource Facility which provides cutting-edge proteomics capabilities to UM investigators.

Prof. Alexey Nesvizhskii

Click To Read Bio

Marc Wilkins

Categories: Keynote Speakers, Main Congress Speakers
Marc Wilkins: Australia

In 1994 Marc Wilkins developed the concept of the proteome and coined the term. In 1997 he co-wrote and co-edited the first book on proteomics. Since that time, Marc has published >250 peer-reviewed research papers, review papers and book chapters and has edited 2 books in the field of proteomics, genomics and systems biology. In proteomics, a recent focus has been to construct a complete methylproteome network in a model organism, and to study its regulatory properties. In genomics, recent highlights have included the sequencing and assembly of the koala genome and collaborative work in the RNA atlas project.

In industry, Marc has co-founded two biotechnology companies. Proteome Systems Limited (1999), in which he worked for 6 years, was a proteomics diagnostics and technology development company. Regeneus (2007) is a regenerative medicine company that recently licensed its core product to a Japanese multinational. At UNSW, Marc is a Professor of Systems Biology. He has been Director of the Ramaciotti Centre for Genomics since 2011 and has grown that to be the largest such facility at any Australian university.

Marc is an elected member of the Council of HUPO, and was a co-organiser of HUPO2010 in Sydney and then HUPO2019 in Adelaide. Marc also serves as an elected member of the Australian Proteomics Society’s Committee of Management.

Marc Wilkins

Click To Read Bio

György Marko Varga

Categories: Keynote Speakers, Main Congress Speakers
György Marko Varga: Sweden

The major research foci of György Marko-Varga are clinical studies, drug characterisation within Cancerous disease and Biobanking.

GYORGY is the Head of the European Cancer Moonshot Lund Center, with a focus on Melanoma and Lung Cancer.

Malignant Melanoma is the most frequently mutated tumor type with approx 50% of the cases harbor activating BRAF mutations, that is the key driver. Large scale studies are undertaken in multi-center studies, currently establishing the largest Molecular Pathology database with 700 patients and resulting 65 million sequence files, where most WHO Melanoma classes have been mapped and characterized.

We have developed digital pathology image libraries, establishing a morphology index pathology basis with a single cell annotation resolution, targeting clone specificificity of Melanoma cancer cell types, as well as stromal phenotypes that interplay and generates an initiation of the Metastasis spread.

ProteoGenomics expression on whole tumor sections, tumor compartments, and clone specific expressions are generated – adressing metastasis activation and developments, as well as mode-of-drug-action mechanisms, and the challenges realting to resistence and Cancer relapses.

Our major objective within the European Cancer Moonshot Center is to build medical knowledge on an individual patient basis by applying ProteoGenomics positioned in the heart of Cancer clinics, collaborating with oncologists, surgery and pathologists.

György Marko Varga

Click To Read Bio

Dr. Neil Kelleher

Categories: Keynote Speakers, Main Congress Speakers
Dr. Neil Kelleher: USA
Neil L. Kelleher, PhD is the director of the 50-person Proteomics Center of Excellence and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. His research is focused in the areas of top-down proteomics, natural products discovery, and cancer biology. Dr. Kelleher and his team drives both technology development and applications of very high performance mass spectrometry in proteomics and metabolomics. For bacteria and fungi, new platforms now feed compounds from the natural world into pharmaceutical pipelines.  In proteomics, Kelleher has emerged as a leading voice in a calling for an analogue of the Human Genome Project applied to human proteins.  This effort is called the Human Proteoform Project and has recently been endorsed by research consortia.  Neil is a serial entrepreneur with experience in spinning up four small companies, including a software shop providing the leading search engine used in >1000 labs for “top down proteomics”. His contributions to the fields of proteomics and natural products chemistry have been recognized by multiple awards, including the Biemann Medal from the American Society for Mass Spectrometry, the Pfizer Award in Enzyme Chemistry from the American Chemical Society, a Searle Scholar Award, a Packard Fellowship, and the Allen Distinguished Investigator Award.
Basic metrics for the Kelleher academic operation are:  H-factor ~75; >380 total publications; 50 Ph.D. students; >150 postdoctoral trainees.

Dr. Neil Kelleher

Click To Read Bio

Dr. Mikhail Savitski

Categories: Keynote Speakers, Main Congress Speakers
Dr. Mikhail Savitski: Germany
PhD in mass spectrometry at Uppsala university 2007. Group leader at Cellzome GSK from 2008-2015. Team leader and head of proteomics core facility at EMBL since 2016. The research group at EMBL develops novel proteomic technologies and applies them to study post-translational regulation.

Dr. Mikhail Savitski

Click To Read Bio

Dr. Kiyoko Aoki-Kinoshita

Categories: Keynote Speakers, Main Congress Speakers
Dr. Kiyoko Aoki-Kinoshita: Japan

Glycoinformatics researcher since 2003, responsible for the glycan repository GlyTouCan, the glycomics MS repositories GlycoPOST (raw data) and UniCarb-DR (glycans), which are all accessible from the glycoscience Web portal GlyCosmos.

Dr. Kiyoko Aoki-Kinoshita

Click To Read Bio

Dr. Jennifer van Eyk

Categories: Keynote Speakers, Main Congress Speakers
Dr. Jennifer van Eyk: USA
Dr. Jennifer Van Eyk is currently the director of the Advanced Biosystems Research Institute at Cedars-Sinai Medical Center, LA and she also holds the inaugural Erika Glazer Endowed Chair in Women’s Heart Health. Dr. Van Eyk’s lab focuses on developing technical pipelines for de novo discovery and larger scale quantitative mass spectrometry methods for the continuous assessments of cohorts focusing on health assessment. The Precision Biomarkers Laboratories, an outgrowth of her lab, is comprised of three independent commercial laboratories, aimed at facilitating the move from discovery to clinical assays for personalized biomarkers. Current, she is part of the Innovation Center, driving single cell phenotyping of patients samples for individualized therapy development.

Dr. Jennifer van Eyk

Click To Read Bio

Dr. Jean Armengaud

Categories: Keynote Speakers, Main Congress Speakers
Dr. Jean Armengaud: France

Jean Armengaud is specialized in mass spectrometry for biology and more specifically in proteogenomics and metaproteomics. He manages the ProGénoMIX platform located near Avignon in France. He wishes to contribute to a better understanding of the functioning of complex biological systems and exploit this knowledge for medical and environmental purposes. He received his PhD in Biochemistry in 1994 at the University of Grenoble.

Dr. Jean Armengaud

Click To Read Bio

Dr. Ashok Dongre

Categories: Keynote Speakers, Main Congress Speakers
Dr. Ashok Dongre: USA
Ashok Dongre is currently Scientific Director & Head of Proteomics in the Research & Early Development organization at Bristol Myers Squibb. He also manages the Genetically Modified Animal Alliances group.
Earned his B.Sc. & M.Sc. in Chemistry from University of Mumbai and Ph.D. in Analytical Chemistry (Vicki Wysocki) at Virginia Commonwealth University. Ph.D research led to the formulation of the “Mobile Proton Model” which elucidates peptide ion fragmentation mechanisms. Trained as HHMI post-doc at University of Washington with Alexander Rudensky & John Yates III.
Over 24-year tenure at BMS, his team is focused on innovating in proteomics space to address challenges at the intersection of disease pathophysiology and bio-pharmaceutical research. He served on NIH and NIAA review panels. He is a peer reviewer for several scientific journals.
Current research includes applying innovative methods to rapidly maturing novel therapeutic modality of Targeted Protein Degradation. This modality garners the potential to unlock the undruggable proteome bringing novel therapies to patients with unmet medical need. Group continues to elucidate innovative biomarker hypothesis across pathologies ranging from cancer to auto immunity and heart failure.
Authored / co-authored over 46 peer-reviewed scientific publications and numerous (>60) presentations. Three issued US Patents each with foreign equivalents.

Dr. Ashok Dongre

Click To Read Bio

Asst. Prof. Justyna Fert-Bober

Categories: Keynote Speakers, Main Congress Speakers
Asst. Prof. Justyna Fert-Bober: USA

I am an Assistant Professor at Cedars-Sinai Heart Institute, with a broad background of biochemistry, molecular biology, immunology, and proteomics to study organ function and regulation in health and disease. My research involves inter-institutional collaborations focused on identifying novel and/or largely understudied biologic markers of heart failure (HF) with the major role of proteins posttranslational modifications (PTMs). I am pioneer in the understanding of arginine deiminases, enzymes family that introduce PTM, called citrullination and their contributions to many processes, like aging, inflammation, and their link with disease development and progression. Uncovering these biological bases are long term goals of my lab expanding to other physiological or pathological conditions. In fact, the COVID-19 pandemic experience has profoundly impact research at my lab and our work has been focuses on i) sex and race differences in both susceptibility and response to SARS-CoV-2 exposure and response to SARS-COV-2 infection; ii) sex and race differences in both positive and negative response to SARS-CoV-2 vaccine, and iii) linking adaptive immune response – autoimmunity with Long COVID, post-acute sequelae of SARS-CoV-2 infection. The concept of profiling autoantibodies in healthy and disease patients combined with multi-omic data will form the basis of disease prediction allowing for earlier intervention linked to disease prevention strategies, as well as earlier, effective and personalized interventions for established disease.

Asst. Prof. Justyna Fert-Bober

Click To Read Bio

Asst. Prof. Jennifer Geddes McAlister

Categories: Keynote Speakers, Main Congress Speakers
Asst. Prof. Jennifer Geddes McAlister: Canada

Dr. Jennifer Geddes-McAlister started her appointment as Assistant Professor in the Department of Molecular and Cellular Biology at the University of Guelph in July 2018. She is an expert in mass spectrometry-based proteomics following a Alexander von Humboldt post-doctoral fellowship at the Max Planck Institute of Biochemistry (Germany). Her research program aims to define the relationship between host and pathogen during infection to uncover new strategies for overcoming resistance in both medically- and agriculturally-relevant diseases. Dr. Geddes-McAlister is the elected Vice President, Communications and Board member for the Canadian National Proteomics Network (CNPN), co-Founder of the Canadian Proteomics and Artificial Intelligence Research and Training Consortium (CanProAI), and the elected Western Hemisphere Diversity Candidate for the Human Proteome Organization (HUPO). She recently founded ‘Moms in Proteomics’, an initiative dedicated to mentoring and supporting mothers in STEM and foudnded the CNPN Unity initiative to promote equity, diversity, and inclusion in proteomics research and training across Canada.

Asst. Prof. Jennifer Geddes McAlister

Click To Read Bio

Assoc. Prof. Ryan Kelly

Categories: Keynote Speakers, Main Congress Speakers
Assoc. Prof. Ryan Kelly: USA
Ryan Kelly received his Ph.D. in analytical chemistry from Brigham Young University (BYU) in 2005 and spent the next 13 years at Pacific Northwest National Laboratory. He joined the Chemistry faculty of BYU as an Associate Professor in 2018. A central theme of Dr. Kelly’s research has been the development of new technological solutions for ultrasensitive biochemical analyses. He has developed ultra-low-flow electrospray ionization sources, improved MS ion optics and custom separations based on nanoflow liquid chromatography and capillary electrophoresis. Dr. Kelly’s efforts have recently focused on single-cell, spatial and other low-input MS-based proteomic analyses. His team developed the nanoPOTS workflow, which enables in-depth profiling of protein expression from single cells and makes possible high-resolution proteome imaging of tissues. His research continues to focus on improvements in sensitivity, throughput and quantification for single-cell proteomics and other sample-limited analyses. Dr. Kelly has authored or coauthored more than 100 publications and is a named inventor on several patents that have been licensed and commercialized by companies including Bruker, Cellenion and MicrOmics Technologies. His work has been recognized with several awards including R&D 100 awards, the Georges Guiochon HPLC Faculty Fellowship and the HTC Innovation Award.

Assoc. Prof. Ryan Kelly

Click To Read Bio

Assoc. Prof. Renã Robinson

Categories: Keynote Speakers, Main Congress Speakers
Assoc. Prof. Renã Robinson: USA
Dr. Renã A. S. Robinson, Associate Professor of Chemistry at Vanderbilt University and inaugural Dorothy J. Wingfield Phillips Chancellor’s Faculty Fellow, received her B.S. in Chemistry with concentration in Business from the University of Louisville and Ph.D. in Analytical Chemistry from Indiana University under the mentorship of Professor David Clemmer. She developed proteomics methods to study aging in Drosophila (fruit flies) and continued working in aging as a Lyman T. Johnson Postdoctoral Fellow with Professor D. Allan Butterfield at the University of Kentucky. During this fellowship she began to focus on neurodegenerative disorders such as Alzheimer’s disease and received a UNCF/Merck Postdoctoral Fellowship.
Dr. Robinson joined the Department of Chemistry at the University of Pittsburgh as Assistant Professor in 2009 and moved to Vanderbilt University in 2017. She has a nationally and internationally recognized research program and is a leader in the field of proteomics for her work in aging, Alzheimer’s disease, and applications relevant to human health and disparities. Her laboratory is especially focused on using advancing proteomics and lipidomics technologies to further understanding of health disparities in Alzheimer’s disease. Dr. Robinson is a Co-Investigator of the Recruitment Innovations for Diversity Enhancements NIH Award to understand the effectiveness of storytelling as a recruitment tool into Alzheimer’s disease research. She is an active member of several organizations serving underrepresented students and professionals in STEM, and is the President of the National Organization for the Professional Advancement of Black Chemists and Chemical Engineers (NOBCChE) and the faculty advisor for the Nashville Student and Professional Chapter of NOBCChE.

Assoc. Prof. Renã Robinson

Click To Read Bio

Assoc. Prof. Morten Thaysen-andersen

Categories: Keynote Speakers, Main Congress Speakers
Assoc. Prof. Morten Thaysen-Andersen: Australia
A/Prof Morten Thaysen-Andersen heads the Analytical Glycoimmunology group at Macquarie University, Sydney, Australia. His research program aims to advance our understanding of the human innate immune system and immune-related diseases including microbial infections, inflammation and cancer. His team develops and applies powerful glycomics and glycoproteomics technologies using advanced mass spectrometry while also drawing on analytical tools in protein and carbohydrate chemistry and methods in immunology, structural biology and molecular biology to unravel glycobiological processes of the innate immune system.

Assoc. Prof. Morten Thaysen-andersen

Click To Read Bio

Assoc. Prof. Jens Michael Schroeder

Categories: Keynote Speakers, Main Congress Speakers
Assoc. Prof. Jens Michael Schroeder: Germany
Dr. Schröder graduated in chemistry, received his diploma in chemistry 1976, and finished 1980 his Doctoral thesis in Organic Chemistry. 1979 he joined the Dpt. of Dermatology at the Kiel University as research assistant to study the role of neutrophils and chemotaxins in psoriasis. In 1984 he discovered in psoriatic scale extracts a novel chemotactic peptide, later named Interleukin 8 or CXCL-8. In 1994 Dr. Schröder was appointed as professor for the biochemistry of inflammation and became head of a Clinical Research Unit until his retirement in 2015. After discovery of the first human inducible peptide antibiotic beta-defensin-2 in 1997, again isolated from psoriatic scales, and the discovery of several other antimicrobial peptides from human skin, he became founder and thereafter speaker of the collaborative research center (SFB) “Molecular Mechanisms of Epithelial Defense” and later a co-founder of the Excellence Initiative “Inflammation at Interfaces”. 2011 he organized as co-chair a Gordon Research Conference on “Antimicrobial Peptides”. He has been a member of the editorial board of various international journals, received several prestigious awards and is member of the German National Academy of Sciences, Leopoldina.
He discovered or co-discovered several important molecules or its function, among them the chemokines IL-8, Gro-alpha, RANTES, Eotaxin, the antimicrobial peptides hBD-2, hBD-3, RNase-7, Psoriasin, cationic intrinsically disordered antimicrobial peptides (CIDAMPs) like Hornerin and Filaggrin-2, and the protease-inhibitors elafin, SPINK-9, SPINK-6, as well as chemotic lipids like 5-oxo-eicosanoids and a fungal diacylated urea. He contributed to the understanding of the role of ß-defensins as factors linking innate and adaptive immunity as well as understanding the role of cathelicidin in the psoriasis pathogenesis. He received the prestigious high risk “Reinhart-Koselleck”-grant of the DFG to investigate “resistance-avoiding antimicrobial principles of healthy human skin”.
Most of his discovered molecules were purified from lesional psoriatic scale extracts and subsequently characterized.

Assoc. Prof. Jens Michael Schroeder

Click To Read Bio

Assoc. Prof. Christine Vogel

Categories: Keynote Speakers, Main Congress Speakers
Assoc. Prof. Christine Vogel: USA
Dr. Christine Vogel is a trained biochemist with a Master’s in Mathematical Biology and a PhD in Computational Structural Biology obtained from the University of Cambridge, with Drs. Cyrus Chothia and Sarah Teichmann. After post-doctoral work with Dr. Edward Marcotte (Univ. of Texas at Austin), she joined New York University as faculty in 2011. Her lab uses a combination of proteomics, transcriptomics, computational, and targeted approaches to investigate the regulation of protein expression under stress. Her work was recognized by the US Human Proteomics Organization with the 2017 Robert J. Cotter New Investigator Award. The work is funded by the NIH and Chan Zuckerberg Initiative.

Assoc. Prof. Christine Vogel

Click To Read Bio

Assoc. Prof. Andreas Mund

Categories: Keynote Speakers, Main Congress Speakers
Assoc. Prof. Andreas Mund: Denmark
Andreas Mund is an associate professor in the clinical proteomics group of Professor Matthias Mann at the Novo Nordisk Foundation Center for Protein Research, University of Copenhagen. He has a dual education profile with a degree in biotechnology engineering from the Anhalt University of Applied Sciences and a PhD in protein biochemistry from the University of Hamburg. His research focuses on the characterization of single cell identity and heterogeneity in tissue biobank samples by a combination of high parametric imaging, artificial intelligence, and ultrahigh sensitive proteomics. This ‘Deep Visual Proteomics (DVP)’ technology deciphers the spatial molecular dimension by quantifying thousands of proteins in an unbiased manner. DVP couples in an unbiased way the physiological features of cells as seen in the microscope with the actual protein signature to understand mechanisms of health and disease.

Assoc. Prof. Andreas Mund

Click To Read Bio

Anjali Seth

Categories: Keynote Speakers, Main Congress Speakers
Anjali Seth: France

Anjali Seth studied Physics and Chemistry in Paris. She obtained her PhD from Pierre and Marie Curie University for her research on magnetic nanoparticles for targeted drug delivery and imaging. She then moved to Oxford, UK, for a postdoctoral project on magnetic particles and ultrasound for cancer theranostics. In 2019, she joined Cellenion, a company specialized in the field of single-cell isolation, to develop and lead the single cell proteomics R&D department. Since then, she had the opportunity to participate in the advancement of the cutting-edge field of single cell proteomics analyses using mass spectrometry. In Cellenion, she focuses on developing tools to facilitate and automate sample preparation workflows prior to analysis. Cellenion is now collaborating with most of the key opinion leader in the field.

Anjali Seth

Click To Read Bio

Sponsored Content